Literature DB >> 12503038

Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).

Fariborz Mansour-Ghanaei1, Mohammad S Fallah, Afshin Shafaghi, Mahmood Yousefi-Mashhoor, Naghi Ramezani, Farshid Farzaneh, Reza Nassiri.   

Abstract

BACKGROUND: The aim of this study was to determine the seroprevalence of hepatitis B and C viruses and abnormal liver function tests among hemophiliacs in Guilan province, Iran. MATERIAL/
METHODS: Patients registered with Guilan Hemophilia Society (GHS) were enrolled in this study, and evaluated for the presence of hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV-Ab) and liver function tests.
RESULTS: One hundred and one patients (100 males, 1 female, mean age 19.7 years, range 3-71 years) from 110 registered hemophiliacs were enrolled in this study. 29 patients (28.7%) had elevated Alanine aminotransferase (ALT), 27 (26.7%) and 72 (71.3%) were positive for HBsAg and HCV-Ab, respectively. Seropositivity for HCV-Ab correlated with the duration of treatment with clotting factor until 1997 (P=0.01). There was also an inverse correlation between factor VIII &amp; IX activity and seropositivity for HCV-Ab (P<0.001) and HBsAg (P<0.04). HCV-Ab was more likely to be positive among those received lyophilized factor VIII and cryoprecipitate than lyophilized factor VIII alone (P<0.01). In addition HCV-Ab seropositivity was more common among those received factor IX concentrate and fresh frozen plasma (FFP) than those received only FFP (P<0.01).
CONCLUSIONS: Based upon our finding, prevalence of HBsAg positive cases in Guilan province was higher than other studies. Although frequency of HCV-Ab was similar to other studies, frequency of increased ALT was less. Upon the results emerged from this study, we recommend that all hemophiliacs should be vaccinated against HBV and should have regular program for checking HCV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503038

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  13 in total

Review 1.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

4.  Prevalence of chronic hepatitis B infection in Iran: a review article.

Authors:  Jalal Poorolajal; Reza Majdzadeh
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

5.  Haemophilia in the developing countries: the Iranian experience.

Authors:  Peyman Eshghi; Mitra Mahdavi-Mazdeh; Mehran Karimi; Mohammad Aghighi
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

6.  Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis.

Authors:  Seyed Moayed Alavian; Seyed Hossein Aalaei-Andabili
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

7.  Clinical profile of hemophilia patients in Jodhpur Region.

Authors:  Vikas Payal; Pramod Sharma; Vishnu Goyal; Rakesh Jora; Manish Parakh; Deepika Payal
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

8.  The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C.

Authors:  Danesh Kadjbaf; Maryam Keshvari; Seyed Moayed Alavian; Ali Pouryasin; Bita Behnava; Shima Salimi; Leila Mehrnoush; Pegah Karimi Elizee; Heidar Sharafi
Journal:  Hepat Mon       Date:  2016-05-03       Impact factor: 0.660

9.  Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran.

Authors:  Mohammad Ali Assarehzadegan; Mehri Ghafourian Boroujerdnia; Khodamorad Zandian
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

10.  Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study.

Authors:  Alireza Ansari-Moghaddam; Mohammad Reza Ostovaneh; Batool Sharifi Mood; Esmail Sanei-Moghaddam; Amirhossein Modabbernia; Hossein Poustchi
Journal:  Hepat Mon       Date:  2012-09-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.